SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-287957

SYN-039

[SYN] Alpha Draco · 57y · Male · Chinese · BMI 26.8 · ECOG 1
SVMC - Sunway Velocity · Cardiothoracic Surgery · Dr. Ng Wei Sheng
IIB (T3, N0)Stable
RET
Clinical storyline

[SYN] Alpha Draco, a 57-year-old Chinese male (current, 36 pack-years, ECOG 1), presented in 2023-12 with incidental finding on routine health screening cxr. Workup confirmed Adenocarcinoma (Stage II, RET). The MDT recommended curative-intent surgery. Current status: Stable.

HPE Results
Adenocarcinoma: Acinar, RET fusion
Clinical Stage
IIB (T3, N0)
Pathological Stage
IIB (T3, N0, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
8.7
Tumor (CT/PET)
3.4 cm
PET SUV
6.33
NGS Results
RET fusion positive (KIF5B-RET)